- Home
- VALU vs KALV Comparison
VALU vs KALV Comparison
Compare VALU & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- KALV
- Stock Information
- Founded
- VALU 1931
- KALV N/A
- Country
- VALU United States
- KALV United States
- Employees
- VALU N/A
- KALV N/A
- Industry
- VALU Investment Managers
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- KALV Health Care
- Exchange
- VALU Nasdaq
- KALV Nasdaq
- Market Cap
- VALU 379.7M
- KALV 362.2M
- IPO Year
- VALU N/A
- KALV N/A
- Fundamental
- Price
- VALU $39.55
- KALV $10.03
- Analyst Decision
- VALU
- KALV Strong Buy
- Analyst Count
- VALU 0
- KALV 8
- Target Price
- VALU N/A
- KALV $25.67
- AVG Volume (30 Days)
- VALU 6.6K
- KALV 334.3K
- Earning Date
- VALU 03-14-2025
- KALV 03-10-2025
- Dividend Yield
- VALU 3.03%
- KALV N/A
- EPS Growth
- VALU 26.35
- KALV N/A
- EPS
- VALU 2.36
- KALV N/A
- Revenue
- VALU $35,859,000.00
- KALV N/A
- Revenue This Year
- VALU N/A
- KALV N/A
- Revenue Next Year
- VALU N/A
- KALV N/A
- P/E Ratio
- VALU $16.76
- KALV N/A
- Revenue Growth
- VALU N/A
- KALV N/A
- 52 Week Low
- VALU $32.94
- KALV $7.30
- 52 Week High
- VALU $57.68
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- VALU 47.31
- KALV 59.09
- Support Level
- VALU $32.94
- KALV $8.99
- Resistance Level
- VALU $34.77
- KALV $11.00
- Average True Range (ATR)
- VALU 1.32
- KALV 0.57
- MACD
- VALU 0.76
- KALV 0.11
- Stochastic Oscillator
- VALU 89.69
- KALV 57.08
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under well-known brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and The Most Trusted Name in Investment Research. Its only operating segment being Publishing.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.